PodParley PodParley
PodParley
ASH Management of Relapsed/Refractory Disease in AYAs with Acute Lymphoblastic Leukemia – Overview episode artwork

EPISODE · Mar 2, 2026 · 2 MIN

ASH Management of Relapsed/Refractory Disease in AYAs with Acute Lymphoblastic Leukemia – Overview

from Clinical Guideline InSights · host Guideline Central

An update of the 2026 ASH Management of Relapsed/Refractory Disease in Adolescents and Young Adults with Acute Lymphoblastic Leukemia guideline, published by the American Society of Hematology on February 11, 2026. Guideline Summary: https://www.guidelinecentral.com/guideline/5084999/Full-Text: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006479/566562/ASH-2026-Guidelines-for-Management-of-Relapsed

Episode metadata supplied by the publisher feed · Published Mar 2, 2026

Embed this episode

NOW PLAYING

ASH Management of Relapsed/Refractory Disease in AYAs with Acute Lymphoblastic Leukemia – Overview

0:00 2:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Guideline InSights?

This episode is 2 minutes long.

When was this Clinical Guideline InSights episode published?

This episode was published on March 2, 2026.

Can I download this Clinical Guideline InSights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!